ECL vs LAB · P/E 35, rev $4.01B vs rev $174.4M
Ecolab Inc (ECL) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. LAB currently screens at market cap $317.1M.
Not investment advice. Open the ECL and LAB stock pages for the full models.
Not investment advice.